Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
85,945,965
-
Share change
-
+8,120,196
-
Total reported value
-
$428,901,612
-
Put/Call ratio
-
156%
-
Price per share
-
$4.99
-
Number of holders
-
185
-
Value change
-
+$38,226,055
-
Number of buys
-
77
-
Number of sells
-
93
Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q4 2021
As of 31 Dec 2021,
INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by
185 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,945,965 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, D. E. Shaw & Co., Inc., WASATCH ADVISORS INC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and GOLDMAN SACHS GROUP INC.
This page lists
185
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.